Company Website: Kelyniam Global, Inc.
Kelyniam Global, Inc to revolutionize the medical industry with FDA Approved Polymer products.
This week's pick is KLYG – Kelyniam Global, Inc. This company could be the next mover in the market place. This is why:
Video Link : YouTube - kelyniam Global, Inc Video
CEO Interview Link: (KLYG) Kelyniam Global, Inc Initial Interview - Investment Nation Forums
KLYG recently received a technology research grant from the State of Connecticut and has made significant advancements in the use of Bio-CADCAM technology such as providing near perfect replicated Cranial implants to replace damaged bone structures.
On Tuesday September 1st, they announced in a press release Kelyniam Global, Inc. Breaks the Mold and Addresses Share Holders on Investment Nation.
Mr. James Ketner, President and CEO, stated, "I am pleased to have done my company's initial interview with Jeff Montange, CEO of Investment Nation - Stock message Boards, quotes news and more. The website has ever-growing popularity and is one of the least biased I've seen in terms of content. Our plan is to keep share holders better informed through transparency and from what we have seen so far, Investment Nation is the best place for Kelyniam Global to achieve this. This is also why we have another interview scheduled for the 3rd week of September in which share holders may participate."
KLYG’s business model is quite ingenious by Utilizing Kelyniam’s existing relationships with Doctors , medical facilities and universities worldwide for Kelyniam’s FDA APPROVED POLYMER’s TO MAKE ARTIFICIAL HIPS, BONES and CRANIAL IMPLANTS.
We believe once discovered in the market place that brokers, hedge funds and bank institutions will pick this up. One hedge fund already has taken a position within Kelyniam.
Just imagine, Doctors being able to use Kelyniam’s FDA Approved Polymer products to cut the wait time for Implants by 90%, eliminate potential complications before and after surgery and speed up patient recovery time by eliminating the use of hammers, saws, pins , titanium rods and other items during invasive surgery.
KLYG is one of the first and only companies looking to introduce its FDA Approved Polymer products to the medical industry on a "Massive Worldwide" scale.
Authorized Stock 20,000,000 common shares
Outstanding Stock 19,272,600 common shares
Tradable Float 4,193,300 common shares
->The company has no Preferred Stock or Options that convert into Common Stock<-
Outstanding Stock 19,272,600 common shares
Tradable Float 4,193,300 common shares
->The company has no Preferred Stock or Options that convert into Common Stock<-
Kelyniam Global, Inc to revolutionize the medical industry with FDA Approved Polymer products.
This week's pick is KLYG – Kelyniam Global, Inc. This company could be the next mover in the market place. This is why:
Video Link : YouTube - kelyniam Global, Inc Video
CEO Interview Link: (KLYG) Kelyniam Global, Inc Initial Interview - Investment Nation Forums
KLYG recently received a technology research grant from the State of Connecticut and has made significant advancements in the use of Bio-CADCAM technology such as providing near perfect replicated Cranial implants to replace damaged bone structures.
On Tuesday September 1st, they announced in a press release Kelyniam Global, Inc. Breaks the Mold and Addresses Share Holders on Investment Nation.
Mr. James Ketner, President and CEO, stated, "I am pleased to have done my company's initial interview with Jeff Montange, CEO of Investment Nation - Stock message Boards, quotes news and more. The website has ever-growing popularity and is one of the least biased I've seen in terms of content. Our plan is to keep share holders better informed through transparency and from what we have seen so far, Investment Nation is the best place for Kelyniam Global to achieve this. This is also why we have another interview scheduled for the 3rd week of September in which share holders may participate."
KLYG’s business model is quite ingenious by Utilizing Kelyniam’s existing relationships with Doctors , medical facilities and universities worldwide for Kelyniam’s FDA APPROVED POLYMER’s TO MAKE ARTIFICIAL HIPS, BONES and CRANIAL IMPLANTS.
We believe once discovered in the market place that brokers, hedge funds and bank institutions will pick this up. One hedge fund already has taken a position within Kelyniam.
Just imagine, Doctors being able to use Kelyniam’s FDA Approved Polymer products to cut the wait time for Implants by 90%, eliminate potential complications before and after surgery and speed up patient recovery time by eliminating the use of hammers, saws, pins , titanium rods and other items during invasive surgery.
KLYG is one of the first and only companies looking to introduce its FDA Approved Polymer products to the medical industry on a "Massive Worldwide" scale.
